Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

July 22, 2011

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

July 14, 2011

Lycopene may help prevent prostate cancer in African Americans
Lycopene, a red pigment that gives tomatoes and certain other fruits and vegetables their color, could help prevent prostate cancer, especially in African American men, according to new research at the University of Illinois at Chicago. Lycopene is a potent antioxidant, and some studies have shown that diets rich in tomatoes may lower the risk of certain cancers, especially those of the prostate, lung and stomach.
Read article at medicalxpress.com

July 13, 2011

Omega-3 reduces anxiety and inflammation in healthy students
A new study gauging the impact of consuming more fish oil showed a marked reduction both in inflammation and, surprisingly, in anxiety among a cohort of healthy young people. The findings suggest that if young participants can get such improvements from specific dietary supplements, then the elderly and people at high risk for certain diseases might benefit even more.
Read article at medicalxpress.com

July 13, 2011

Nuts may help prevent diabetes, suggests study
Daily consumption of nuts may help to control type 2 diabetes, and prevent its complications, according to new research. The study, published in Diabetes Care, reports that consuming two ounces of nuts daily as a replacement for carbohydrates may be an effective glycemic and serum lipid control for people with Type 2 diabetes. “Mixed, unsalted, raw, or dry-roasted nuts have benefits for both blood glucose control and blood lipids and may be used as part of a strategy to improve diabetes control without weight gain,” said lead author Dr. David Jenkins, from the University of Toronto.
Read article at nutranigredients.com

For more natural health news, click here.

See also our 2001-2010 news archive, by clicking here.

Pharma "Business with Disease" News

July 14, 2011

Breathe Deeply: Spiriva Studies Show Troubling Pattern Of Serious Heart Risks, If You Know Where To Look
Last month, a widely publicized study raised concerns about the safety of the blockbuster Spiriva inhaler that is used to treat chronic obstructive pulmonary disease. The meta-analysis published in the British Medical Journal found that, when administered in the mist form known as Respimat, there was a 52 percent increase in mortality risk compared with a placebo (see here).
Read article at pharmalot.com

July 12, 2011

Mass psychosis in the US
How Big Pharma got Americans hooked on anti-psychotic drugs.
Has America become a nation of psychotics? You would certainly think so, based on the explosion in the use of antipsychotic medications. In 2008, with over $14 billion in sales, antipsychotics became the single top-selling therapeutic class of prescription drugs in the United States, surpassing drugs used to treat high cholesterol and acid reflux. Once upon a time, antipsychotics were reserved for a relatively small number of patients with hard-core psychiatric diagnoses - primarily schizophrenia and bipolar disorder - to treat such symptoms as delusions, hallucinations, or formal thought disorder. Today, it seems, everyone is taking antipsychotics. Parents are told that their unruly kids are in fact bipolar, and in need of anti-psychotics, while old people with dementia are dosed, in large numbers, with drugs once reserved largely for schizophrenics. Americans with symptoms ranging from chronic depression to anxiety to insomnia are now being prescribed anti-psychotics at rates that seem to indicate a national mass psychosis.
Read article at aljazeera.net

July 12, 2011

The Professor, A Paxil Study & Misconduct Charges
A University of Pennsylvania psychiatry professor is alleging that several colleagues - including his department chair - allowed their names to be added to a medical journal manuscript but gave control of the contents to GlaxoSmithKline. The study, which was funded by the drugmaker and the National Institutes of Health, looked at the impact of the Paxil antidepressant on patients with bipolar disorder. Moreover, the professor, Jay Amsterdam, also claims the 2001 study, which was published by the American Journal of Psychiatry (see here), was ghostwritten by Scientific Therapeutics Information. The same firm has previously been cited for ghostwriting activities in connection with Paxil, including a book that was published in 1999 by the American Psychiatric Association (read this). The published study did not acknowledge that STI played any role.
Read article at pharmalot.com

July 5, 2011

Polypharmacy increases risk of death in over-65s
A UK-based study of over 13,000 people aged over 65 has found that patients taking multiple drugs in a certain unnamed class are at a significantly greater risk of death, but only scratches the surface of the problems with polypharmacy.
Read article on the Alliance for Natural Health (Europe) website

July 4, 2011

Firms’ freebies for NHS staff under scrutiny
The world’s biggest drug companies could find themselves the target of investigation by Britain’s fraud watchdog over allegations that they have been influencing NHS staff with lavish travel junkets and hospitality.
Read article in the Gulf Times (Qatar)

For more pharma "business with disease" news, click here.

See also our 2001-2010 news archive, by clicking here.

GMO News

July 14, 2011

GMO maize damage may total billions, says expert
The damage to Hungary's agriculture caused through sowing genetically modified seeds and to the country's GMO-free status will total billions of forints, an expert told MTI on Wednesday.
Read article at caboodle.hu (Hungary)

July 7, 2011

Voluntary Guidelines Set to Allow Labeling for Genetically Modified Food Worldwide
After nearly two decades of struggling for consensus within the global food safety body, the Codex Alimentarius Commision, the U.S. ended its opposition to the genetically modified (GM) labeling guidance document on Tuesday, July 5, 2011, allowing it to move forward to become official Codex text. Though this new agreement does not require mandatory labeling, it will allow countries wishing to adopt GM food labeling without fear of legal challenges from the World Trade Organization (WTO), because national measures based on Codex guidelines cannot be challenged as a barrier to trade.
Read article on the eNews Park Forest website (Illinois, USA)

For more GMO news, click here.

See also our 2001-2010 news archive, by clicking here.

Other Health-related News

July 14, 2011

Codex avoids implosion - by five votes
Ractopamine Almost Shoved Down the Throats of 70% of World's Pork Consumers Who Don't Want It
It was high drama worthy of any best-selling spy thriller as intrigue and rumors of blackmail coursed through the room with near reckless abandon. Passions were high and stances adamant. With such an electric atmosphere, one could have thought that nations were being partitioned, or even put to the sword. Yet, for us, the essential reality was not that distant a cousin. There were countries trying to impose their will on the majority, trying to pollute the World with a poison that would injure many millions. The stakes were serious. Surprisingly, the battlefield for this drama was in a modern, air-conditioned meeting hall rented by the Codex Alimentarius Commission (CAC) for its 34th session in Geneva, Switzerland this last week of July 4-9, 2011.
Read article on the website of the National Health Federation (USA)

July 13, 2011

EU Regulators and Monsanto Exposed for Hiding Glyphosate Toxicity
A damning report co-authored by an international group of scientists and researchers for non-government organisation Open Earth Source (OES) reveals that studies from industry including those from Monsanto since the 1990s showed glyphosate caused birth defects and the European Commission approved the herbicide in full knowledge of those finding. Glyphosate is the active ingredient in Monsanto’s Roundup herbicide and over a hundred other commercial formulations. It is the cause of great concern as evidence of its harmful effects keep piling up from independent scientific studies in recent years, including endocrine disruption, DNA damage, reproductive and developmental toxicities, neurotoxicity, cancer, and birth defects.
Read article on the Institute of Science in Society (ISIS) website (UK)

July 12, 2011

European Medicines Agency reports on progress of EU herbal directive
We hate to say, “We told you so!”, but these results confirm in black-and-white many of the THMPD’s fundamental flaws and limitations. Across 27 Member States, in European countries that use hundreds – if not thousands – of herbal species as the basis of traditional medicinal systems, a mere 83 species are used as the basis for products registered until the end of December 2010. All of these species are European herbs. This means, unless a given Member State is prepared to exempt a herb from medicinal licensing – as is being considered under the proposed statutory regulation of herbalists in the UK – or the form of the herb delivered to consumers is regarded as a food or food supplement, all herbs associated with the great non-European traditions become illegal in the EU. This includes includes Ayurveda, TCM and all African and south American traditions.
Read article on the website of the Alliance for Natural Health (Europe)

July 9, 2011

Roman-era shipwreck reveals ancient medical secrets
A first-aid kit found on a 2,000-year-old shipwreck has provided a remarkable insight into the medicines concocted by ancient physicians to cure sailors of dysentery and other ailments. A wooden chest discovered on board the vessel contained pills made of ground-up vegetables, herbs and plants such as celery, onions, carrots, cabbage, alfalfa and chestnuts – all ingredients referred to in classical medical texts. The tablets, which were so well sealed that they miraculously survived being under water for more than two millennia, also contain extracts of parsley, nasturtium, radish, yarrow and hibiscus.
Read article in the Daily Telegraph (UK)

July 6, 2011

Herbal medicines in Europe - Italy shows way out of impasse
In 2004, the European Community has published a directive regarding traditional herbal medicinal products which requires a pharmaceutical registration of medicinal herbs. After a period of transition, which finished in May of 2011, it is now forbidden to sell such traditional herbal medicinal products or - as they are called in the UK - herbal remedies, without the necessary registration. But there is a problem. The registration of medicinal herbs under the directive is extremely difficult. In order to get out of this impasse, the Italian associations Assoerbe and SISTE have been promoting a project to support the use of aromatic and healthy herbs in foods.
Read article by Sepp Hasslberger at laleva.org (Italy)

For more health-related news, click here.

See also our 2001-2010 news archive, by clicking here.

Political News

July 15, 2011

Poll: British People Overwhelmingly Ready to Leave EU
The people of Great Britain have had enough of the European Union and its growing financial difficulties. In fact, according to a recent poll, if they had a choice in the matter, the British would leave the EU as soon as possible.
Read article in The New American (USA)

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.


Back to the Newsletter Archive…